Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
July 09, 2012
Announced in May 2009 by President Obama, the Global Health Initiative (GHI) promised a new way for the United States to do business in global health. Fragmented U.S. programs would be united under a single banner; vertical structures would be dismantled in favor of an integrated approach; and narro...
Blog Post
December 20, 2011
The United States budget for 2011; red area is global health aid (Source: xkcd)
This is a joint post with Amanda Glassman.
The verdict is out (sort of): the proposed total global health appropriation for FY2012 will be $8.3 billion; $600m less than 2011 appropriations, $38.3m higher than the e...
Blog Post
December 07, 2010
This is a joint post with Connie Veillette. It is cross-posted on the Global Health Policy blog.
The QDDR pre-release consultation document says the Global Health Initiative will eventually be managed by USAID. For a number of reasons, it makes complete sense for USAID to lead the GHI.
Heal...
REPORTS
August 24, 2010
This report focuses on the workforce strengthening strategies of three of the major HIV/AIDS donors—the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund), and the World Bank’s Africa Multi-country HIV/AIDS Progra...
HIV/AIDS MONITOR ANALYSIS
August 04, 2008
Donors spend billions of dollars to fight HIV/AIDS in developing countries, but poor integration between donors and host country health systems risks undermining international efforts to prevent and treat AIDS. In this analysis, CGD’s HIV/AIDS Monitor argues that donors need to pay more attention t...
HIV/AIDS MONITOR ANALYSIS
March 05, 2007
In response to both public health imperative and unprecedented political pressure, aid to fight HIV/AIDS has increased massively in recent years: global funding to combat the disease in low- and middle-income countries has more than tripled since 2001, from $2.1 billion to an estimated $8.9 billion ...